§ BIOTECHNOLOGY
USD · Biotechnology

GERN

GERON CORP
USDSector · BiotechnologyBeta · 0.67
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
138 increased/new, 67 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/B3.73EPS (TTM)-0.13
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
RA CAPITAL MANAGEMENT, L.P.63.8M1.0%±0%
BlackRock, Inc.47.3M0.0%+3%
Soleus Capital Management, L.P.41.5M2.5%+78%
Deep Track Capital, LP31.7M0.8%−2%
State Street30.5M0.0%+14%
VANGUARD CAPITAL MANAGEMENT LLC26.7Mn/an/a
◇ AC INTELLIGENCE

Top institutional owners for GERN as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER38.2% · 0 holders
OTHER37.2% · 177 holders
DEALER / BANK8.7% · 34 holders
PASSIVE / INDEX7.7% · 9 holders
QUALITY / COMPOUNDER4.1% · 15 holders
TACTICAL / MACRO3.3% · 3 holders
SYSTEMATIC / QUANT0.6% · 3 holders
INCOME / DEFENSIVE0.2% · 13 holders
GROWTH / MOMENTUM0.1% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for GERN in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention GERN yet.